Human brains today contain 50% more plastic than in 2016, a new study found. Brain of people diagnosed with dementia had the ...

Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services ...

This acquisition introduces Apotex into the strategically growing Canadian health and wellness sector, leveraging its existing channel presence in pharmacies and expanding its channels to include ...

Jupiter Neurosciences Inc., a clinical-stage pharmaceutical company developing JOTROL, a patented resveratrol-based platform, ...

JUPITER, FL - Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage pharmaceutical company currently valued at $34.1 million, has announced a partnership with Catalent (NYSE:CTLT) Pharma ...

Apotex Inc. ("Apotex" or "the Company"), the largest Canadian-based pharmaceutical company, announced today that it has acquired CanPrev, a leading Canadian provider of vitamins, supplements, and ...

MIAMI and BARRANQUILLA, Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: PROC) (“Procaps” or the “Company”), a leading ...

JOTROL is designed to overcome the historical challenges of resveratrol by significantly enhancing bioavailability while minimizing gastrointestinal side effects. The upcoming Phase 2a trial will ...

Jupiter Neurosciences (JUNS) announced it has entered into an agreement with Catalent Pharma Solutions for the production of JOTROL softgel ...

The approval of Amneal Pharmaceuticals’ generic version of rifaximin 550 mg oral tablets is tentative due to the product’s ...